‘We have already lost time’: Europe’s belated biotech ambitions

EU PERSPECTIVES - Europe risks falling behind in health innovation as policymaking struggles to match the speed of global shocks. The continent's regulatory culture, while rooted in good intentions, may be costing it ground in the global race for life sciences and biotechnology. That is the view of Lutz Dommel, CEO of RPP Group, speaking at the Health Policy Leaders Event at the European Parliament. Read more

Lutz Dommel, CEO of the RPP Group, together with MEPs Marta Timido, Stine Bosse and Vlad Voilescu, recipients of the top 10 most influential health policymakers.